About

This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Children’s National Health System, QIAGEN, Maryland Tech Council, University System of Maryland and MedImmune/AstraZeneca. Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. So please join us for our Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

2018 Agenda

8:00 AM: ARRIVAL

Registration, Breakfast, Networking

8:45 AM: WELCOMING REMARKS

 MODERATORS:
Jeffrey M. Gallagher, CEO, Virginia Bio
Tami Howie, CEO, Maryland Tech Council

8:55 AM: STATE OF THE ECOSYSTEM

KEYNOTE:
Rich Bendis, President & CEO, BioHealth Innovation Inc.

9:15 AM: STRENGTHENING THE UNIVERSITY-CORPORATE CONNECTION – BIOTECH AND BEYOND: A Conversation with University Presidents

MODERATOR:
Brian Fitzgerald, CEO, Business-Higher Education Forum

SPEAKERS:
Dr. Wallace D. Loh, President, University of Maryland, College Park
Jay A. Perman, MD, President, University of Maryland, Baltimore

10:00 AM: PANEL – UNIVERSITIES: FROM RESEARCH TO COMMERCIALIZATION

MODERATOR:
Christy Wyskiel, Senior Advisor to the President, Johns Hopkins Technology Ventures
PANELISTS:
Geoffrey Lynn, CSO, Avidea Technologies
Andrew Ishizuka, PhD, Chief Scientific Officer, Avidea Technologies
Eduardo Davila, PhD, Co-Leader, UMGCCC Tumor Immunotherapy Program, University of Maryland School of Medicine
Ron Dudek, Founder & President, Living Pharma

11:00 AM: NETWORKING BREAK

 

11:30 AM: BIOHEALTH REGIONAL STRENGTHS: IMMUNE-ONCOLOGY, CELL THERAPY & VACCINES

MODERATOR:
John Mumm, PhD, Director, Immunoncology R&D, MedImmune

PANELISTS:
William Hearl, Founder & CEO, Immunomic Therapeutics
Matthew Mulvey, PhD, Founder & CEO, Benevir
Jeff Ulmer, Head, Pre-clinical R&D, GSK

11:30 AM: EMERGING REGIONAL CLUSTERS: DIGITAL HEALTH, DEVICES AND AUGMENTED REALITY

MODERATOR:

William E. Bentley, Robert E. Fischell Distinguished Chair & Inaugural Director of the Robert E. Fischell Institute for Biomedical Devices

PANELISTS:
Milton Brown, CSO, Shuttle Pharmaceutical
Praduman Jain, Founder & CEO, Vibrent Health

Emanuel Petricoin, CSO, Perthera Inc.
Dr. Amitabh Varshney, Dean of the Computer of Computer, Mathematical and Natural Sciences, University of Maryland

12:00 PM: LUNCH

1:30 PM: PANEL: ANGEL INVESTORS: WHERE ARE THEY? WHAT DO THEY WANT? HOW DO I ACCESS THEM?

INTRODUCTION BY:
John Trainer, Vice President & Head, Partnering & Strategy, MedImmune

MODERATOR:
Jonathan Aberman, Managing Director, Amplifier Ventures

PANELISTS:
Jeff Galvin, CEO & Founder, American Gene Technologies International Inc.
Merom Klein, Principal, Courage Growth Partners
Dendy Young, Managing Partner, McLean Capital LLC

2:30 PM: PANEL: INVESTORS WITH A LOCAL PRESENCE

MODERATOR:
Andy Jones, Chief Investment Officer, TEDCO

PANELISTS:
Peter Jobse, Managing Director, Inova Strategic Investments
Joel S. Marcus, Chairman, Chief Executive Officer and Founder, Alexandria Real Estate Equities, Inc., and Alexandria Venture Investments
Cherine Eldumiati Plumaker, Managing Director, Pansend Life Sciences, LLC
David A. Present, MD, President & Senior Managing Director, Panned Life Sciences, LLC
R. Jacob Vogelstein, Partner & Portfolio Manager, Camden Partners Holdings, LLC

3:30 PM: NETWORKING BREAK

4:00 PM: KEYNOTE SPEAKER

TO BE CONFIRMED

4:20 PM: NIST DIRECTOR, DR. WALTER G. COPAN

Keynote:
Dr. Walter G. Copan, Under Secretary of Commerce for Standards and Technology and NIST Director

4:40 PM: DAY ONE CLOSING REMARKS

KEYNOTE:
John Trainer, Vice President & Head, Partnering & Strategy, MedImmune

5:00 PM: GENERAL RECEPTION

8:00 AM: ARRIVAL

Registration, Breakfast, Networking

8:30 AM: KEYNOTE – LESSONS LEARNED STARTING COMPANIES AND GROWING A BIOTECH HUB IN TORONTO

KEYNOTE:
Aled Edwards, PhD, Director & CEO, Structural Genomics Consortium

9:00 AM: CRAB TRAP

MODERATOR:
Rich Bendis, President & CEO, BioHealth Innovation Inc.

JUDGES:
Shaun Grady, Vice President, Business Development Operations, AstraZeneca
Sara Nayeem, Partner, New Enterprise Associates
Paul Silber, Founding Principal, Blu Venture Investors
Robert Silverman, Head, Externalized Drug Discovery Partnering, Roche
Steven Zachary, Associate, Sands Capital Ventures

10:10 AM: BHCR Spotlight

SPEAKER:
James C. Powers, Chairman & CEO, HemoShear Therapeutics

10:20 AM: NETWORKING BREAK

10:45 AM: TALES OF CEOs

MODERATOR:
Barbara Kunz, Global Chief Executive, Drug Information Agency

PANELISTS:
David Hilbert, President & CEO, Arcellx
Angela Graham, CEO, Quality Biological
Rachel King, CEO, GlycoMimetics
Anne Lindblad, President & CEO, Emmes

10:45 AM: TALES OF CSOs

MODERATOR:
Steve Projan, PhD, FAAM, Senior Vice President & Head, iMED, Infectious Diseases and Vaccines, MedImmune

PANELISTS:
Olivier Danos, CSO, RegenX Bio
W. James Jackson, CSO, Emergent
Ashish Kulkarni, Executive Vice President & Chief Technology Officer, Avatar
Benjamin Solomon, Managing Director, Genedx

11:45 AM: LUNCH

12:45 PM: PUBLIC SUPPORT FOR BIOHEALTH ENTREPRENEURS

MODERATOR:
Beth Meagher, Federal Strategy Leader, Deloitte

PANELISTS:
Rich Bendis, President & CEO, BioHealth Innovation Inc.
Jeffrey M. Gallagher, CEO, Virginia Bio
Tami Howie, CEO, Maryland Tech Council
Bret Schreiber, Senior Director, Office of BioHealth and Life Sciences, Maryland Department of Commerce

1:45 PM: KEYNOTE

TO BE CONFIRMED

2:45 PM: USING PATIENT INPUT TO DRIVE AND IMPROVE BIOMEDICAL INNOVATION

PANELISTS:
Lisa Guay-Woodford, Principal Investigator, Clinical and Translational Science Institute, Children’s National Health System
Marshall Summar, MD, Director, Rare Disease Institute, Children’s National Medical Center

3:15 PM: ROLE OF HOSPITALS IN CATALYZING HEALTH INNOVATION

SPEAKERS:
Kurt Newman, President & CEO, Children’s National Health System
Todd Stottlemyer, President, Inova Center for Personalized Health

4:00 PM: CLOSING REMARKS

KEYNOTE:
Rich Bendis, President & CEO, BioHealth Innovation Inc.

2018 Speakers

Jonathan Aberman

Jonathan Aberman

Managing Director, Amplifier Ventures

Rich Bendis

Rich Bendis

President and CEO of BioHealth Innovation Inc.

William E. Bentley

William E. Bentley

Robert E. Fishcell Distinguished Chair in Engineering, University of Maryland

Jarrod Borkat

Jarrod Borkat

Senior Director, External Partnerships & Collaborations, MedImmune

Dr. Walter G. Copan

Dr. Walter G. Copan

Under Secretary of Commerce for Standards and Technology and NIST Director

Jeffrey M. Gallagher

Jeffrey M. Gallagher

CEO, Virginia Bio

Jeff Galvin

Jeff Galvin

CEO & Founder, American Gene Technologies International Inc.

Douglas Goldstein

Douglas Goldstein

AVP, Business Development, and Innovation Officer, Inova

Shaun Grady

Shaun Grady

Vice President, Business Development Operations, AstraZeneca

Bill Hearl, PhD

Bill Hearl, PhD

CEO, Immunomic Therapeutics, Inc.

Tami Howie

Tami Howie

CEO, Maryland Tech Council

Andrew Ishizuka, PhD

Andrew Ishizuka, PhD

Chief Scientific Officer, Avidea Technologies

W. James Jackson, PhD

W. James Jackson, PhD

Senior Vice President & Chief Scientific Officer, Emergent BioSolutions

Peter Jobse

Peter Jobse

Managing Director, Inova Strategic Investors

Merom Klein, PhD

Merom Klein, PhD

Principal, Courage Growth Partners

Douglas Liu

Douglas Liu

Senior Vice President, Global Operations, Qiagen

Dr. Wallace D. Loh

Dr. Wallace D. Loh

President, University of Maryland, College Park

Joel S. Marcus

Joel S. Marcus

Chairman, Chief Executive Officer and Founder, Alexandria Real Estate Equities Inc., and Alexandria Venture Investments

Beth Meagher

Beth Meagher

Principal and Leader, Federal Strategy and Translational Medicine Practices, Deloitte Consulting LLP

Matthew Mulvey, PhD

Matthew Mulvey, PhD

CEO, BeneVir Biopharm, Inc.

John Mumm, PhD

John Mumm, PhD

Director, Immunoncology R&D, MedImmune

Sara Nayeem, MD

Sara Nayeem, MD

Partner, New Enterprise Associates

Jay A. Perman, MD

Jay A. Perman, MD

President, University of Maryland, Baltimore

James C. Powers

James C. Powers

Chairman & CEO, HemoShear Therapeutics

Cherine Eldumiati Plumaker

Cherine Eldumiati Plumaker

Managing Director, Pansend Life Sciences LLC

David A. Present, MD

David A. Present, MD

President & Senior Managing Director, Pansend Life Sciences LLC

Steve Projan, PhD, FAAM

Steve Projan, PhD, FAAM

Senior Vice President & Head, iMED, Infectious Diseases & Vaccines, MedImmune

Bret Schreiber

Bret Schreiber

Senior Director, Office of BioHealth and Life Sciences, Maryland Department of Commerce

Paul Silber, PhD

Paul Silber, PhD

Founding Principal, Blu Venture Investors

Robert Silverman

Robert Silverman

Head, External Drug Discovery, Roche Partnering

Marshall Summar, MD

Marshall Summar, MD

Director, Rare Disease Institute, Children's National Medical Center

John Trainer

John Trainer

Vice President, Partnering & Strategy, MedImmune

Dr. Amitabh Varshney

Dr. Amitabh Varshney

Dean of the College of Computer, Mathematical, and Natural Sciences, University of Maryland

R. Jacob Vogelstein

R. Jacob Vogelstein

Partner & Portfolio Manager, Camden Parters Holdings, LLC

Christy Wyskiel

Christy Wyskiel

Senior Advisor to the President, Johns Hopkins Technology Ventures

Dendy Young

Dendy Young

Managing Partner, McLean Capital LLC

Crab Trap

2018 BHCR Crab Trap

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum.

Application Deadline: March, 30th 2018 

Finalists will be announced: April 9th, 2018 

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application

crabtrap

Sponsored by:

WSGR-logo_0

Present at the BioHealth Capital Region Forum on April 24, 2018
Five finalists will have a chance to win the grand prize by presenting in
front of a panel of prominent industry funding experts and executives including:

  • Rich Bendis (Moderator), President & CEO, BioHealth Innovation, Inc.
  • Shaun Grady, VP, Strategic Partnering & Business Development, AstraZeneca
  • Sara Nayeem, Partner, New Enterprise Associates (NEA)
  • Dr. Paul Silber, Founding Principal, Blu Venture Investors
  • Robert Silverman, Head Externalized Drug Discovery Partnering, Roche
  • Stephen Zachary, Associate, Sands Capital Ventures

    Grand Prize

    $10,000

    Incubation Space in Montgomery County, MD or  Prince William County, VA

    Business Mentoring

    CRITERIA
    Product
    Technical Feasibility
    Marketing/Strategy
    Leadership Team
    Financial/Projection

    APPLY NOW »

Combologos

Register